S Sorof

528 total citations
24 papers, 441 citations indexed

About

S Sorof is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, S Sorof has authored 24 papers receiving a total of 441 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 9 papers in Cancer Research and 6 papers in Oncology. Recurrent topics in S Sorof's work include Cancer, Hypoxia, and Metabolism (4 papers), Peroxisome Proliferator-Activated Receptors (4 papers) and Carcinogens and Genotoxicity Assessment (3 papers). S Sorof is often cited by papers focused on Cancer, Hypoxia, and Metabolism (4 papers), Peroxisome Proliferator-Activated Receptors (4 papers) and Carcinogens and Genotoxicity Assessment (3 papers). S Sorof collaborates with scholars based in United States and Canada. S Sorof's co-authors include R P Custer, James A. Bassuk, P N Tsichlis, Tibor Keler, Christopher S. Barker, Quentin Tonelli, Stanley A. Vinores, John J. Churey, Kerim Münir and Livio Luongo and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Experimental Cell Research and Advances in experimental medicine and biology.

In The Last Decade

S Sorof

22 papers receiving 403 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
S Sorof United States 11 323 152 109 59 44 24 441
Recaredo Infante France 12 272 0.8× 115 0.8× 53 0.5× 52 0.9× 32 0.7× 23 623
R.M. Kaikaus United States 9 435 1.3× 128 0.8× 77 0.7× 102 1.7× 27 0.6× 12 579
Hilde Nebb Sørensen Norway 10 335 1.0× 40 0.3× 62 0.6× 51 0.9× 36 0.8× 15 458
Christos Hadjiagapiou United States 13 386 1.2× 62 0.4× 54 0.5× 36 0.6× 49 1.1× 15 641
K Miyamoto Japan 8 228 0.7× 189 1.2× 160 1.5× 10 0.2× 47 1.1× 12 640
Tokuhiko Higashi Japan 11 313 1.0× 57 0.4× 43 0.4× 69 1.2× 15 0.3× 41 455
Ranjan Mehta United States 12 361 1.1× 80 0.5× 61 0.6× 16 0.3× 138 3.1× 20 547
Mark T. Yates United States 13 204 0.6× 86 0.6× 94 0.9× 11 0.2× 99 2.3× 19 731
Alexei J. Likhachev Russia 14 372 1.2× 82 0.5× 298 2.7× 11 0.2× 53 1.2× 29 631
L. C. Smith United States 7 272 0.8× 50 0.3× 73 0.7× 33 0.6× 23 0.5× 13 492

Countries citing papers authored by S Sorof

Since Specialization
Citations

This map shows the geographic impact of S Sorof's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S Sorof with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S Sorof more than expected).

Fields of papers citing papers by S Sorof

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S Sorof. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S Sorof. The network helps show where S Sorof may publish in the future.

Co-authorship network of co-authors of S Sorof

This figure shows the co-authorship network connecting the top 25 collaborators of S Sorof. A scholar is included among the top collaborators of S Sorof based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S Sorof. S Sorof is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Keler, Tibor, et al.. (1997). Liver Fatty Acid Binding Protein and Mitogenesis in Transfected Hepatoma Cells. Advances in experimental medicine and biology. 400A. 517–524. 8 indexed citations
3.
Sorof, S, et al.. (1994). Liver fatty acid-binding protein: specific mediator of the mitogenesis induced by two classes of carcinogenic peroxisome proliferators.. Proceedings of the National Academy of Sciences. 91(3). 848–852. 48 indexed citations
4.
Keler, Tibor, Christopher S. Barker, & S Sorof. (1992). Specific growth stimulation by linoleic acid in hepatoma cell lines transfected with the target protein of a liver carcinogen.. Proceedings of the National Academy of Sciences. 89(11). 4830–4834. 47 indexed citations
5.
Sorof, S, et al.. (1990). Preferential binding of growth inhibitory prostaglandins by the target protein of a carcinogen.. Proceedings of the National Academy of Sciences. 87(23). 9401–9405. 66 indexed citations
6.
Münir, Kerim, R P Custer, & S Sorof. (1989). Normal hepatocytes exhibiting histone H3 with antibody accessible sites that are cryptic in carcinogen-altered hepatocytes.. PubMed. 49(2). 424–32. 5 indexed citations
7.
Münir, Kerim, Gary R. Blackburn, & S Sorof. (1988). Late target protein of the carcinogen N-2-fluorenylacetamide in rat liver.. PubMed. 48(23). 6745–52. 1 indexed citations
8.
Bassuk, James A., P N Tsichlis, & S Sorof. (1987). Liver fatty acid binding protein is the mitosis-associated polypeptide target of a carcinogen in rat hepatocytes.. Proceedings of the National Academy of Sciences. 84(21). 7547–7551. 61 indexed citations
9.
Sorof, S & R P Custer. (1987). Elevated expression and cell cycle deregulation of a mitosis-associated target polypeptide of a carcinogen in hyperplastic and malignant rat hepatocytes.. PubMed. 47(1). 210–20. 17 indexed citations
10.
Sorof, S, et al.. (1985). Induction of epidermoid differentiation by cyclic adenine nucleotide in cultured mammary tumors of mice.. PubMed. 45(4). 1828–33. 5 indexed citations
11.
Custer, R P & S Sorof. (1984). Target polypeptide of a carcinogen is associated with normal mitosis and carcinogen-induced hyperplasias in adult hepatocytes.. Proceedings of the National Academy of Sciences. 81(21). 6738–6742. 35 indexed citations
12.
Sorof, S, et al.. (1982). General process of induction of squamous metaplasia by cyclic adenine nucleotide and prostaglandins: mouse prostate glands.. PubMed. 42(9). 3682–7. 6 indexed citations
13.
Sorof, S, et al.. (1979). Prevention of transformation of mammary gland by retinoid in whole organ culture. Abstr.. The Mouseion at the JAXlibrary (Jackson Laboratory). 71. 2 indexed citations
14.
Tonelli, Quentin, R P Custer, & S Sorof. (1979). Transformation of cultured mouse mammary glands by aromatic amines and amides and their derivatives.. PubMed. 39(5). 1784–92. 27 indexed citations
15.
Sorof, S, et al.. (1978). Evidence for similar principal target proteins of chemical carcinogens in six carcinogen-organ systems. Abstr.. The Mouseion at the JAXlibrary (Jackson Laboratory). 37. 1 indexed citations
16.
Sorof, S, et al.. (1967). Inhibition of cell multiplication in vitro by liver arginase.. PubMed. 7. 25–37. 10 indexed citations
17.
Sorof, S, et al.. (1967). The nature of the inhibition of replication of cultured cells by a liver macromolecule.. PubMed. 7. 15–24. 6 indexed citations
18.
Sorof, S, et al.. (1960). Electrophoretic distribution of derivatives of 2-acetyl-aminofluorene-9-14C bound to soluble proteins of rat liver in vivo. Experimental Cell Research. 20(1). 253–256. 14 indexed citations
19.
Sorof, S, et al.. (1960). Improved protein resolution of concentrated tissue extract in zonal column electrophoresis. Biochimica et Biophysica Acta. 38. 559–561. 4 indexed citations
20.
Sorof, S & P P Cohen. (1951). Modified semi-micro- and micro-waring blendors for low temperature use. Experimental Cell Research. 2(2). 299–300. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026